Science Explorer Interactive view Map

SilaGene (United States)

Research works
3
▼ 80% vs 2013–17
Citations
28
8.8 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
92%
world 28%

Not ranked overall: SilaGene (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does SilaGene (United States) publish most on?

By volume in 2022–2025: Glioma Diagnosis and Treatment, Microtubule and mitosis dynamics, Cancer therapeutics and mechanisms and Genomics, phytochemicals, and oxidative stress.

  1. 1 Glioma Diagnosis and Treatment Genetics 0 works
  2. 2 Microtubule and mitosis dynamics Cell Biology 0 works
  3. 3 Cancer therapeutics and mechanisms Molecular Biology 0 works
  4. 4 Genomics, phytochemicals, and oxidative stress Molecular Biology 0 works
  5. 5 Brain Metastases and Treatment Pulmonary and Respiratory Medicine 0 works
  6. 6 Bioactive Compounds and Antitumor Agents Toxicology 0 works
  7. 7 ATP Synthase and ATPases Research Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available92.2%not open7.8%

World: 28% of research is openly available.

with international co-authors7.8%domestic only92.2%

World: 19% is written across borders.

How has SilaGene (United States)'s research output changed?

Output in 2018–2022 was 80% lower than in 2013–2017.

2015
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in New Brunswick

All research institutions in New Brunswick

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.